Tenon Medical, Inc. (TNON)
NASDAQ:TNON
Want to see TNON full AI Analyst Report?
TNON Stock Chart & Stats
$1.00
-$0.13(-5.94%)
At close: 4:00 PM EST
$1.00
-$0.13(-5.94%)
Day’s Range― - ―
52-Week Range$0.58 - $2.48
Previous CloseN/A
Volume74.29K
Average Volume (3M)87.93K
Market Cap
$7.14M
Enterprise Value$4.73M
Total Cash (Recent Filing)$4.61M
Total Debt (Recent Filing)$4.88M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Aug 12, 2026EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.33
Shares Outstanding11,573,428
10 Day Avg. Volume106,258
30 Day Avg. Volume87,930
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.39
Price to Sales (P/S)1.78
P/FCF Ratio-0.64
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue1.02
Enterprise Value/Gross Profit1.59
Enterprise Value/Ebitda-0.41
Forecast
1Y Price Target
$2.63Price Target Upside162.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.85
Revenue Forecast (FY)$6.42M
Bulls Say, Bears Say
Bulls Say
Sustained Margin ExpansionThe material margin step-up reflects better unit economics and fixed-cost absorption from recent product mix and scale. Sustaining high‑60s margins reduces the revenue needed to approach breakeven and enhances long-term profitability potential if procedure volumes continue to grow and manufacturing efficiencies persist.
Early Commercial TractionRapid Q1 revenue growth and physician training indicate tangible adoption of the SI joint platform. A growing base of trained surgeons and a physical training center support durable conversion of procedures, creating recurring procedure flow and a foundation for sustained revenue growth as market penetration increases.
Growing IP And Product PipelineAn expanding patent portfolio and staged product rollouts strengthen differentiation and raise barriers to entry. Multiple planned launches (incremental Symmetry Plus features and a third approach) provide recurring catalysts and durable competitive advantages tied to proprietary tech and an expanding procedural offering.
Bears Say
Persistent Cash BurnSustained, large negative operating cash flow implies the business cannot self‑fund near-term growth and is dependent on external financing. Continued high burn increases dilution and refinancing risk, forcing management to prioritize liquidity over longer-term investments unless revenue scale materially improves.
Near-Term Financing CliffShort-dated convertible debt extends runway but creates a funding cliff and possible dilution upon conversion. The notes' steep original-issue discount, conversion mechanics and maturity compress flexibility, raising the likelihood of further financings or dilutive outcomes if operational cash generation lags expectations.
Elevated Leverage And Compliance RiskHigher leverage alongside a small equity base reduces financial flexibility and heightens solvency risk. Combined with a Nasdaq minimum-stockholders'-equity deficiency notice, the company faces structural governance and listing risks that could limit strategic options and distract management from commercial execution.
Tenon Medical, Inc. News
TNON FAQ
What was Tenon Medical, Inc.’s price range in the past 12 months?
Tenon Medical, Inc. lowest stock price was $0.58 and its highest was $2.48 in the past 12 months.
What is Tenon Medical, Inc.’s market cap?
Tenon Medical, Inc.’s market cap is $7.14M.
When is Tenon Medical, Inc.’s upcoming earnings report date?
Tenon Medical, Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 56 days.
How were Tenon Medical, Inc.’s earnings last quarter?
Tenon Medical, Inc. released its earnings results on May 12, 2026. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.305 by -$0.005.
Is Tenon Medical, Inc. overvalued?
According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued.
Does Tenon Medical, Inc. pay dividends?
Tenon Medical, Inc. does not currently pay dividends.
What is Tenon Medical, Inc.’s EPS estimate?
Tenon Medical, Inc.’s EPS estimate is -0.24.
How many shares outstanding does Tenon Medical, Inc. have?
Tenon Medical, Inc. has 11,573,428 shares outstanding.
What happened to Tenon Medical, Inc.’s price movement after its last earnings report?
Tenon Medical, Inc. reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.305. Following the earnings report the stock price went down -11.548%.
Which hedge fund is a major shareholder of Tenon Medical, Inc.?
Currently, no hedge funds are holding shares in TNON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tenon Medical, Inc.
Tenon Medical, Inc. is a medical device firm dedicated to developing advanced surgical implant solutions. These systems are designed to enhance sacroiliac joint (SIJ) fixation and fusion operations, ultimately leading to better patient outcomes. The company markets The CATAMARAN SIJ Fusion System, which includes both specialized instruments and implants, specifically engineered for the preparation and secure fusion of the SI-Joint. This product is distributed throughout the United States and Puerto Rico. Founded in 2012, Tenon Medical's operations are headquartered in Los Gatos, California.
TNON Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed clear progress: strong Q1 revenue (~+90% YoY), record gross profit and a large margin expansion (+24 percentage points), tangible commercial and IP investments, and added financing that extends runway. The company still operates at a net loss with OpEx elevated relative to a small revenue base and relies on successful commercial conversion and upcoming product launches to sustain momentum. Overall, the positives (sharp growth, margin gains, funding, IP and training investments) outweigh the risks, though meaningful execution is required to translate momentum into sustained profitability.View all TNON earnings summariesTNON Stock 12 Month Forecast
Average Price Target
$2.63
▲(162.50% Upside)
Technical Analysis
Strata Skin Sciences
―
Lifeward
―
enVVeno Medical
―
PAVmed
―
Heart Test Laboratories, Inc.
―
Ownership Overview
13.19% Insiders
1.15% Mutual Funds
0.99% Other Institutional Investors
84.06% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---